Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04982263
NCT04982263
Completed
Not Applicable

Blood Coagulation Abnormalities in COVID-19 Patients and Correlation With Severity

Sohag University1 site in 1 country125 target enrollmentFebruary 1, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCovid19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Sohag University
Enrollment
125
Locations
1
Primary Endpoint
correlation of disease severity with results of laboratory test
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The role of the coagulation parameters in predicting the severity of COVID-19 disease will be assessed

Detailed Description

In COVID-19 patients the coagulation parameters Prothrombin concentration (PC), Activated Partial Thromboplastin Time (aPTT), D Dimer, Antithrombin III (ATIII) and Fibrinogen are measured and correlation with disease severity is to be investigated

Registry
clinicaltrials.gov
Start Date
February 1, 2021
End Date
May 31, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hend Mohammed Abdelraheem Esmaeel

assistant professor

Sohag University

Eligibility Criteria

Inclusion Criteria

  • •● Confirmed cases with COVID 19

Exclusion Criteria

  • •● Known history of blood coagulopathy disorder

Outcomes

Primary Outcomes

correlation of disease severity with results of laboratory test

Time Frame: Baseline results of coagulation profile and baseline disease severity assessment

The results of blood coagulation profile will be correlated with degree of severity of illness

Secondary Outcomes

  • Agreement of abnormalities in coagulation profile with measured inflammatory markers(baseline measurement of inflammatory markers)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
COVID-19 Associated Coagulopathy in EgyptCoagulopathy
NCT04507230Assiut University106
Completed
Not Applicable
Role of Hematological Parameters in the Stratification of COVID-19 Disease SeverityCovid19
NCT04670328FMH College of Medicine and Dentistry101
Completed
Not Applicable
Platelet Aggregation in COVID-19 PatientsCOVID-19
NCT06097429Mansoura University75
Unknown
Phase 2
Hemostasis in COVID-19: an Adaptive Clinical TrialCOVID-19
NCT04466670University of Sao Paulo General Hospital379
Unknown
Not Applicable
Hemostatic Profile in Patients Affected by COVID-19Covid19Thrombosis
NCT04595110ANNA FALANGA400